Preclinical and Drug Discovery CRO
Explore our case studies to see how REPROCELL partners with clients to deliver data-rich, disease-relevant insights that accelerate drug discovery and de-risk development.
CASE STUDY – IPM: Achieve Regulatory Approval
CASE STUDY – Amgen: Avoid Species Differences
CASE STUDY – Roche: Eliminate Clinical Adverse Effects
CASE STUDY – Bionorica: Evaluating the Spasmolytic Effects of BNO 1095
CASE STUDY – Investigating the Mechanism of Action of a GC-C Agonist Using Human Intestinal Tissue
CASE STUDY – Demonstrating Functional Vascular Safety of a Selective nNOS Inhibitor in Human Resistance Arteries
CASE STUDY – Investigating Human Cardiac and Vascular Effects of Anti‑Arrhythmic Drugs Using Human Functional Tissues